JP2009519986A5 - - Google Patents

Download PDF

Info

Publication number
JP2009519986A5
JP2009519986A5 JP2008546217A JP2008546217A JP2009519986A5 JP 2009519986 A5 JP2009519986 A5 JP 2009519986A5 JP 2008546217 A JP2008546217 A JP 2008546217A JP 2008546217 A JP2008546217 A JP 2008546217A JP 2009519986 A5 JP2009519986 A5 JP 2009519986A5
Authority
JP
Japan
Prior art keywords
receptor
agents
mglu5
diseases
imbalance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008546217A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009519986A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/012181 external-priority patent/WO2007071358A1/en
Publication of JP2009519986A publication Critical patent/JP2009519986A/ja
Publication of JP2009519986A5 publication Critical patent/JP2009519986A5/ja
Pending legal-status Critical Current

Links

JP2008546217A 2005-12-20 2006-12-18 代謝型グルタミン酸受容体のモジュレーターとしてのニコチン酸誘導体 Pending JP2009519986A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05027934 2005-12-20
EP06120424 2006-09-11
PCT/EP2006/012181 WO2007071358A1 (en) 2005-12-20 2006-12-18 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors

Publications (2)

Publication Number Publication Date
JP2009519986A JP2009519986A (ja) 2009-05-21
JP2009519986A5 true JP2009519986A5 (https=) 2010-02-04

Family

ID=37744569

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008546217A Pending JP2009519986A (ja) 2005-12-20 2006-12-18 代謝型グルタミン酸受容体のモジュレーターとしてのニコチン酸誘導体

Country Status (12)

Country Link
US (1) US20090005363A1 (https=)
EP (1) EP1966144A1 (https=)
JP (1) JP2009519986A (https=)
KR (1) KR20080076962A (https=)
AR (1) AR058554A1 (https=)
AU (1) AU2006329007A1 (https=)
BR (1) BRPI0620066A2 (https=)
CA (1) CA2627630A1 (https=)
PE (1) PE20071171A1 (https=)
RU (1) RU2008129622A (https=)
TW (1) TW200732323A (https=)
WO (1) WO2007071358A1 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010502664A (ja) 2006-09-11 2010-01-28 ノバルティス アクチエンゲゼルシャフト 代謝型グルタミン酸受容体の調節剤としてのニコチン酸誘導体
JP5341084B2 (ja) * 2007-08-03 2013-11-13 エフ．ホフマン−ラ ロシュ アーゲー Ｔａａｒ１リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体
AU2008309621A1 (en) * 2007-10-12 2009-04-16 Novartis Ag Metabotropic glutamate receptor modulators for the treatment of Parkinson's Disease
WO2009047303A2 (en) * 2007-10-12 2009-04-16 Novartis Ag Metabotropic glutamate receptor modulators for the treatment of pervasive developmental disorder
MX2010014222A (es) * 2008-06-30 2011-03-29 Novartis Ag Star Combinaciones que comprenden moduladores de mglur para el tratamiento de enfermedad de parkinson.
CN102256963B (zh) * 2008-12-19 2014-06-11 贝林格尔.英格海姆国际有限公司 作为ccr2受体拮抗剂用于治疗炎症、哮喘和copd的环状嘧啶-4-甲酰胺
US8748623B2 (en) 2009-02-17 2014-06-10 Syntrix Biosystems, Inc. Pyridinecarboxamides as CXCR2 modulators
EP2959902A1 (en) 2009-07-23 2015-12-30 Novartis AG Use of azabicycloalkyl derivatives for the treatment or prevention of ataxia
NZ598891A (en) * 2009-08-24 2014-05-30 Neuralstem Inc Synthesis of a neurostimulative piperazine
RU2012116124A (ru) * 2009-09-21 2013-10-27 Вандербилт Юниверсити О-БЕНЗИЛ НИКОТИНАМИДНЫЕ АНАЛОГИ КАК ПОЗИТИВНЫЕ АЛЛОСТЕРИЧЕСКИЕ МОДУЛЯТОРЫ mGluR5
JO3250B1 (ar) 2009-09-22 2018-09-16 Novartis Ag إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7
EP2490691A1 (en) 2009-10-20 2012-08-29 Novartis AG Use of 1h-quinazoline-2,4-diones
ES2674275T3 (es) 2009-12-17 2018-06-28 Centrexion Therapeutics Corporation Antagonistas del receptor CCR2 y usos de los mismos
WO2011149963A1 (en) * 2010-05-24 2011-12-01 Vanderbilt University Substituted-6-methylnicotinamides as mglur5 positive allosteric modulators
AU2011268865A1 (en) 2010-06-24 2013-01-31 Novartis Ag Use of 1H-quinazoline-2,4-diones
EP2608672B1 (en) 2010-08-23 2020-12-16 Syntrix Biosystems, Inc. Aminopyridine- and aminopyrimidinecarboxamides as cxcr2 modulators
AR084515A1 (es) * 2010-12-22 2013-05-22 Merz Pharma Gmbh & Co Kgaa Derivados heterociclicos nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades asociadas al sistema nervioso central tales como parkinson y alzheimer, entre otras
AR084516A1 (es) * 2010-12-22 2013-05-22 Merz Pharma Gmbh & Co Kgaa Moduladores de receptores de glutamato metabotropicos
WO2012101060A1 (en) 2011-01-27 2012-08-02 Novartis Ag Use of nicotinic acetylcholine receptor alpha 7 activators
MX2014002693A (es) 2011-09-07 2014-06-04 Novartis Ag Uso de 1h-quinazolina-2,4-dionas para usarse en la prevencion o el tratamiento de epilepsia fotosensible.
RU2672468C1 (ru) * 2011-12-22 2018-11-15 Конекшис Лайф Сайенсиз Пвт. Лтд. Производные аза-адамантанов и их применение
MX362819B (es) 2013-01-15 2019-02-18 Novartis Ag Uso de agonistas del receptor nicotinico de acetilcolina alfa 7 para el tratamiento de la narcolepsia.
KR101879919B1 (ko) 2013-01-15 2018-07-18 노파르티스 아게 알파 7 니코틴성 아세틸콜린 수용체 작용물질의 용도
TW201444821A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代之哌啶化合物及其作為食慾素受體調節劑之用途
TWI621618B (zh) 2013-03-13 2018-04-21 比利時商健生藥品公司 經取代２－氮雜雙環類及其作為食慾素受體調控劑之用途
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
US10561676B2 (en) 2013-08-02 2020-02-18 Syntrix Biosystems Inc. Method for treating cancer using dual antagonists of CXCR1 and CXCR2
US10046002B2 (en) 2013-08-02 2018-08-14 Syntrix Biosystems Inc. Method for treating cancer using chemokine antagonists
US8969365B2 (en) 2013-08-02 2015-03-03 Syntrix Biosystems, Inc. Thiopyrimidinecarboxamides as CXCR1/2 modulators
JPWO2015098991A1 (ja) * 2013-12-26 2017-03-23 東レ株式会社 Ｎ−アルキルアミド誘導体及びその医薬用途
KR102455043B1 (ko) * 2014-09-11 2022-10-13 얀센 파마슈티카 엔.브이. 치환된 2-아자바이사이클 및 오렉신 수용체 조절제로서의 이의 용도
PT3317270T (pt) 2015-07-02 2020-08-24 Centrexion Therapeutics Corp (4-((3r,4r)-3-metoxitetrahidro-pirano-4-ilamino)piperidina-1-il)(5-metil-6-(((2r,6s)-6-(p-tolil)tetrahidro-2h-pirano-2-il)metilamino)pirimidina-4-il)citrato de metanona
US20190231525A1 (en) 2016-08-01 2019-08-01 Mitraltech Ltd. Minimally-invasive delivery systems
DE102018104201A1 (de) * 2018-02-23 2019-08-29 Westfälische Wilhelms-Universität Münster Verfahren zur Herstellung fluorierten heterocyclischen aliphatischer Verbindungen

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE817911C (de) * 1947-12-16 1951-10-22 Chem Fab Tempelhof Preuss & Te Verfahren zur Darstellung von in 6-Stellung basisch substituierten Pyridin-3-carbonsaeureamiden
WO1999018066A1 (en) * 1997-10-02 1999-04-15 Sankyo Company, Limited Amidocarboxylic acid derivatives
AU9781098A (en) * 1997-10-02 1999-04-27 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
CN1158264C (zh) * 1997-11-21 2004-07-21 Nps药物有限公司 用于治疗中枢神经系统疾病的代谢性谷氨酸受体拮抗剂
DK1196397T3 (da) * 1999-06-02 2006-01-02 Nps Pharma Inc Metabotrope glutamatreceptorantagonister og anvendelse deraf til behandling af sygdomme i centralnervesystemet
WO2001007416A1 (de) * 1999-07-28 2001-02-01 Lonza Ag Verfahren zur herstellung von pyridazincarbonsäurederivaten
US6479510B2 (en) * 2000-08-18 2002-11-12 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
WO2003022214A2 (en) * 2001-09-06 2003-03-20 Millennium Pharmaceuticals, Inc. Piperazine and homopiperazine compounds
US7595311B2 (en) * 2002-05-24 2009-09-29 Exelixis, Inc. Azepinoindole derivatives as pharmaceutical agents
KR101025633B1 (ko) * 2002-09-19 2011-03-30 일라이 릴리 앤드 캄파니 오피오이드 수용체 안타고니스트로서의 디아릴 에테르
US20040067985A1 (en) * 2002-10-04 2004-04-08 Fortuna Haviv Method of inhibiting angiogenesis
NZ551468A (en) * 2003-12-24 2010-05-28 Biota Scient Management Polycyclic agents for the treatment of respiratory syncytial virus infections
WO2005110982A2 (en) * 2004-04-07 2005-11-24 Neurogen Corporation Substituted 1-benzyl-4-substituted piperazine analogues
DE102004020908A1 (de) * 2004-04-28 2005-11-17 Grünenthal GmbH Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen
SE0401969D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Piperidine derivatives
ES2377758T3 (es) * 2004-11-12 2012-03-30 Bristol-Myers Squibb Company Compuestos tricíclicos basados en tiazolo[4,5-b]piridina imidazo-fusionada y composiciones farmacéuticas que los comprenden
WO2006064286A1 (en) * 2004-12-13 2006-06-22 Medivir Uk Ltd Cathepsin s inhibitors
WO2006094639A1 (en) * 2005-03-04 2006-09-14 F.Hoffmann-La Roche Ag Pyridine-2-carboxamide derivatives as mglur5 antagonists

Similar Documents

Publication Publication Date Title
JP2009519986A5 (https=)
NO20084490L (no) Nye forbindelser
WO2008153705A3 (en) Methods of treating, diagnosing and detecting fgf21-associated disorders
ATE469895T1 (de) Cgrp-rezeptorantagonisten
JP2010500116A5 (https=)
MA33058B1 (fr) Composition pharmaceutique solide comprenant de l'amlodipine et du losartan avec stabilite amelioree
ATE526318T1 (de) Farnesoid-x-rezeptor-agonisten
CL2004000526A1 (es) Compuestos derivados de dibenzofurano, carbazoles, inhibidores de fosfodiesterasa tipo 4; procedimiento de preparacion; y su uso en el tratamiento de trastornos y condiciones inflamatorias, del sistema nervioso central y diabetes insulino resistente.
EA200600773A1 (ru) Антагонисты мускариновых ацетилхолиновых рецепторов
ATE520686T1 (de) Azabicycloä3.1.0ühexanderivate und ihre verwendung als modulatoren des dopamin-d3- rezeptors
WO2008007211A8 (en) Substituted n-bicyclicalkyl bicyclic carboxyamide compounds
EA201000428A1 (ru) Оксадиазол- и оксазолзамещенные производные бензимидазола и индола как ингибиторы dgat1
IL185422A0 (en) Pgd2 receptor antagonists for the treatment of inflammatory diseases
NO20085051L (no) Behandling av gastrointestinale forstyrrelser med CGRP-antagonister
ZA200710611B (en) New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases
WO2006099268A3 (en) Cgrp receptor antagonists
NL1032580A1 (nl) Systemen, werkwijzen en apparatuur voor het volgen van de voortschrijding en de behandeling van ziekte door middel van categorie-indices.
WO2007050793A3 (en) Methods and compositions for the treatment of marfan syndrome and associated disorders
WO2006081311A3 (en) Compositions and methods for the intracellular disruption of vegf and vegfr-2 by intraceptors
WO2009015369A3 (en) Isophthalamide derivatives inhibiting beta-secretase activity
NL1030418A1 (nl) Azabenzoxazolen voor de behandeling van CZS-stoornissen.
JP2009523456A5 (https=)
WO2006078554A3 (en) Cgrp receptor antagonists
EP1899318A4 (en) NEW AZETIDINE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS FOR THE TREATMENT OF STOMACH DARM DISEASES
WO2006060542A3 (en) Formulations of substituted benzoxazoles